chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3:30 am woke with massive headache, lot of body aches, no urination for hrs, unable to sleep due to all over pain. Arm extremely sore; took fluids and then had some nausea. This went on for 2 days.  Still very tired, arm still sore..  Used Tylenol for pain.  helps just a little bit.  Did not seek any treatment.
Ms. Siddiqui was observed post Covid-19 immunization for 30 minutes after she complained of rapid heartbeat, VS checked @ 1100 with VS , BP-135/82. HR- 82, offered water and accepted, VS rechecked at 1109, BP-126/82, HR- 72, she is emotional and voices that she believes that she had some anxiety, reports no further issues, she leaves without incident. She was provided with Vaccine Information Sheet and instruction to access the V-Safe system.
Information has been received from a registered nurse referring to a 2 unspecified office staff of unknown age. On an unknown date, the patients were vaccinated with PNEUMOVAX 23 (dose, frequency, lot number, route and indication not provided). In December 2011, the patients experienced fatigue, severe redness at injection site erythema and body aches an unspecified time after receiving the vaccination. The outcome of events was unknown. There was no product quality issue (PQC) involved. Additional information has been requested.
During the morning I noticed the area I received the shot was mildly itchy. Did not notice the itch throughout the day but when  I went to take a shower in the evening I  found the entire upper arm muscle area swollen and red and still itchy.  It could've been there the day before too and I just didn't notice?.
Patient developed rash consistent with varicella 6/10/08. Treated symptomatically with Benadryl.
Arm is red., itchy, and feels like a rash.  Feels like it is burning.
I started to have aches, joint pain and a migraine with slight nausea on 2/1/21 @ 1700 after having the 2nd vaccine earlier that morning. The migraine persisted till 2/3/2021 at 0930. I called employee heath and was suggested to take some Tylenol and coffee. I continue to have mild joint pain, a mild headache, and no nausea.
Patient received vaccine at 13:30. She started feeling anxious after receiving vaccine but went back to work. Patient received 50 mg of diphenhydramine at 14:30, she then started experiencing hives and shortness of breath. She was administer 0.3 mg of epinephrine into the thigh and EMS was called.
Information has been received from a physician concerning a 9 month old Caucasian male pt who on 2/21/00 was vaccinated in the right thigh with a 3rd dose of Hep-B. Subsequently, in 2/00, the pt developed a petechial rash. It was noted that the manufacturer of the 1st dose is unknown and the 2nd dose of Hep-B was Engerix-B. The pt had a similar experience following exposure to varicella virus vaccine live (WAES00072664). No further information is available.
2-3 weeks after 2nd vaccine I developed this lingering cough. Some days it?s mild , some days it?s aggressive. One to two days a month I get achey legs that last 24 hours. Very similar to the side effect after the vaccine
RASH STARTED 2 DAYS AFTER VACCINE ON MY WRISTS, AND SLOWLY WENT UP MY ARMS BY SUNDAY MORNING.  BY MONDAY MORNING RASH WAS ON MY LEGS, CHEST, BACK AND ARMS. ITCHY, RED AND RAISED  WELTS IN PLACES. JUST UNCOMFORTABLE. IT'S NOW WEDNESDAY AND IT'S SLOWLY GOING AWAY, STILL RED AND ITCHY. I DID NOT GO TO MY PCP. I DID SHOW MY RASH TO MY INFECTIOUS DISEASE PHYSICIAN AT OUR HOSPITAL. I HAVE BEEN TAKING AN ANTIHISTAMINE THAT HAS HELPED.
It not like pain like a sharp pain, It's a pianful ache from my elbow up to my shoulder and it doesn't go away even with all my strong medications. It has affected my range of motion. The main range of motion that is limited is if I try to reach behind me for anything it is probably abot 50% limited range of motion. I have gotten many insects bites and when I get a bite on that arm it swells and it seems to be infected.  I am going to see my rheumatologist for a steroid shot.
Start experiencing hives, intermittently was experiencing hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Start experiencing hives, intermittently was experiencing hives) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced URTICARIA (Start experiencing hives, intermittently was experiencing hives). At the time of the report, URTICARIA (Start experiencing hives, intermittently was experiencing hives) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Follow up received on 02-Jun-2021 as email address of the reporter was added.
Bruising around the area approximately 1 inch in diameter, also headache, anxiety, shaking, nauseous, and weakness that occurred about 1 week after shot. Bruising were present shortly after vaccine.
There was a mix up with expiring product coming out of fridge and new product drawn up.  Patient may have received vaccine that was in syringe in fridge longer than the recommended 6 hours.  We contact Pfizer, CDC and our vaccine experts. Microbial contamination was primary concern and there was no recommendation for revaccination. Patient was advised of error and to monitor for signs of infection, i.e. redness at injection site and fever. The patient had no reaction at time of contact and was told to follow up if anything changes.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium
Muscle soreness; Fever; This is a spontaneous report received from a contactable consumer (Patient) as part of Pfizer-sponsored program COVAX  Support. A male patient of an unspecified age received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection) via an unspecified route of administration on 10Feb2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Feb2021, the patient experienced muscle soreness and fever. Caller asking if he will experience the same reactions after the second dose. The outcome of the events were unknown.  Information about batch/lot number has been requested.
Pt reports she got her 2nd covid vaccine Monday and developed a rash over both arms, chest , abd, and back on Tuesday. rash noted on left arm further exam deferred until provider in room. Pt has no c/o pain, itching, shortness of breath and reports no concerns other than rash. Pt reports she is her to have the rash documented but is feeling fine otherwise and has no other concerns.  Denies previous medication allergies or reactions to vaccines.
No adverse reaction - patient was given the incorrect vaccines. Once discovered it happened the patient/parent was notified to get correct vaccine. F/u call 04-29-20 no additional symptoms. Doing well
The next morning, red and swollen arm, a temperature, and malaise. Made an appt with the doctor. No testing ran. He said I had pneumonia when I saw him a few days later. Prescribed antibiotics. This helped. This lasted 4 weeks.
Information has been received from a physician concerning a 61 year old male who on 02-APR-2007 was vaccinated with a 0.65 mL dose of Zostavax. On 10-APR-2007 the patient experienced an itchy rash. The patient sought unspecified medical attention. The patient recovered. There was no product quality complaint. Additional information has been requested.
She got her vaccine, just had a little tiredness.  Then around 4:00-4:30 she started getting nauseous like she had to throw up but then did not.  She had dinner and it didn't stay down, she ate very light.  Then she went to bed early, still nauseous.  She is always nauseous whether she eats or not, she continues to be nauseous.  She has not done much in the last 2 days.  She only weighs 90# and she has lost 3# in the last few days.  She continues to push food even though she is nauseated but knows she has to eat . She states that she will not take any other vaccines.  She did not call her doctor as felt that they would not do anything other than tell her to rest.  Today her nausea is coming and going but hopes tomorrow it may be gone.  She has had flu vaccines for years and has never had any reaction.  She got her latest vaccine in September and had no reaction.
CDC reports: 10 mo child had fever to 104.6 & 1 convuls episode day p/immunization, hospitalized 4 days, lumbar puncture normal.
About five hours after her shot. Her right Hand started itching. The same side she received her shot. She told me it was extremely itchy. She would not stop. I called the Nurse advice line. They told me it was a reaction but they cannot say if it was from the vaccine or not.  The nurse instructed me to use the Benadryl cream that I had. I did so through out the night. In the morning she was much better and the itchy was almost non existent.  After two days  the shot she has experience migraines. She gets them at least twice a week. She has never had migraines before. Unsure if that is from the vaccine or not. She has had no new medicine, no head injury and her environment has not change.  I had reported this to a Doctor who she saw on Oct. 19. However, later found out she did not write anything about it in her chart. I finally got a hold of the Nurse advice line that I had called. The nurse has instructed me to report here.
After first shot on 12/24/2020, I noticed a small rash on my right arm that was quite itchy. After my second dose on 1/14/2021, my rash and itching grew and now I am covered from my neck down to my ankles. I am covered in a red rash/hives, and this is incredibly itchy.
Client received her first dose Pfizer COVID vaccine on 11.04.21, lot number FF8839, exp. 12/31/2021 at 1827. At 1844, client reported to the EMTs that she was having heart beating fast and they transferred her to the zero-gravity chair. PHN assessed client who was alert and oriented x 4. EMT took her vitals at 1848: BP 176/91 (automatic cuff), P 116, O2 Sat. 98%. Client denied shortness of breath, dizziness, or chest pain. Client reported history of anxiety but denied having any chronic illnesses or taking any medications. She reported she has allergies to Hepatitis A or B vaccine (rash), penicillin (itchiness, hot feet), wine and pistachio (swollen throat), shrimp (itchiness, hot feet), and beef (nausea). EMT took her vitals at 1859: BP 156/82 (manual cuff), P 86, O2 Sat. 97% and denied any SOB, dizziness, or chest pain. At 1859, she told her anxiety level is 3/10 and reported her BP increases with anxiety and working out. EMT provided crackers and water at 1907 which client consumed without any issues. EMT took her vitals at 1915: BP 150/82, P 98, O2 Sat. 99% and denied any SOB, dizziness, or chest pain. At 1915, she reported her anxiety was low. PHN educated client on the adverse s/s to look out for at home and the need to seek EMS with the Pfizer fact sheet given to client. PHN educated client on making an appointment with her PCP to check her high blood pressure in case it's not related to anxiety. She verbalized understanding. At 1918, client told her friend will drive her home today and left  vaccination site in a steady gait.
Myalgia, Fever & NauseaVomiting Narrative:  fever lasted for 2 days, fatigue and myalgia lasted for 4 days
Patient requested second Pfizer shot on 07/27/21 over telephone.  Processed and ran GRITS.  I saw he completed Moderna series at 03/31/21 and 04/28/2021.  He confirmed he did get Moderna but wanted Pfizer too for double coverage.  I told him we cannot administer the shot as it's not indicated.  He received Pfizer first dose on 07/06/2021 at 446, but script was released/billed out on 07/18/2021.
I experienced a rash over the past 8 or 9 months and now I have mass cell activation (itch all over my body with red welts & hives on random parts of my body from an intense histamine response since January). I also experienced massive hair loss approximately 2 to 3 months after the vaccine. I went to my Dermatologist and inspected my scalp which she confirmed that indeed I was experiencing Alopecia. I communicated over email with a Dermatologist who felt that my body was mounting an immune response to the vaccine and what I experienced was seen in lots of patients that received the vaccine and their A-Topic Dermatitis pushes their immune system over the edge. My Dermatologist put me on a mid-grade steroid topical prescription (Fluocinonide Acetonide)  to put on my scalp twice per day. I have an appointment to see an Allergists/Immunologist who specializes in Histamine Phenomenon/Mass Cell Activation).
Information has been received from a physician concerning a 10 year old female who in approximately 2007 was vaccinated SC with a second 0.5 mL dose of VARIVAX (Merck). Since that time, the patient developed stress induced lesions, that are both hive like and chickenpox like all over the body. The lesions seem to clear with only OTC BENADRYL as a treatment. No other information was available. Unspecified medical attention was sought through an office visit. The outcome was reported as not recovered. There was no product quality complaint. Additional information has been requested.
Allergic Reaction; Throat swelled; Cough; Difficult to swallow; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERSENSITIVITY (Allergic Reaction), PHARYNGEAL SWELLING (Throat swelled), COUGH (Cough) and DYSPHAGIA (Difficult to swallow) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.  Concurrent medical conditions included Giant cell arteritis since 14-Feb-2021, Blood pressure high (worse due to prednisolone.) since 1998, Drug allergy (allergic to clame reaction experienced as swollen face, eye and throat.) since 1981, Allergy to antibiotic (allergic to clindamycin and erythromycin reactions experienced as swollen throat.) since 2002 and Drug allergy (allergic to iodine reactions experienced as swelling and rash.) since 2003. Concomitant products included PREDNISONE and VALSARTAN (DIOVAN) for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced HYPERSENSITIVITY (Allergic Reaction), PHARYNGEAL SWELLING (Throat swelled), COUGH (Cough) and DYSPHAGIA (Difficult to swallow). On 03-Apr-2021, HYPERSENSITIVITY (Allergic Reaction), PHARYNGEAL SWELLING (Throat swelled), COUGH (Cough) and DYSPHAGIA (Difficult to swallow) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included  Cold water and Cold Compresses.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: follow up information received on 24-may-2021, patient demographic details, dosage regimen, new events, historical and current medical information were updated.
fast heart rate; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (fast heart rate) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (fast heart rate). At the time of the report, HEART RATE INCREASED (fast heart rate) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment drugs were reported
PT STATES THAT FIRST COURSE WAS OK. THE SECOND HURT, HAD A BIG ROUND RED SPOT THAT WAS SENSITIVE, THEN SHARP AGGRAVATING PAIN THAT RADIATES TO THE NECK. VERY DIFFICULT TO RAISE HER LEFT ARM ABOVE HER HEAD.
Almost exactly a week after vaccine localized hives itching, warm to touch for over 24 hrs. Has been relieved with Claratin as of today 12 hrs after taking Claratin.
One episode of fever 101 F; Initial information regarding this unsolicited valid non-serious case was received from a consumer and transmitted to Sanofi on 26-Oct-2020.  This case involved a 48 year old male patient who experienced one episode of fever 101 F (pyrexia), while he received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  Relevant medical history, past medical treatment, vaccination details, concomitant medications and family history were not provided.   On 26-Oct-2020, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed one non-serious episode of fever 101 F (pyrexia) unknown latency following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  On 28-Oct-2020, relevant laboratory test results of COVID-19 showed negative.  Final diagnosis was pyrexia.   No fever medication was given as corrective treatment.  On an unknown date, the patient had recovered from the reported event.  There would be no information available on batch number for this case.
Swelling and warmth with itchiness near injection site about 2 inches wide and 4-5 inches long
WITH IN 4 HRS AFTER RECEIVING THE DTAP THE PATIENT HAD A FEVER OF 103 AND INTENSE SCREAMING PT WOULD NOT WALK ON LEG THIS LASTED FOR 24 HRS.
On 6/3/05, employee visited occupational health for his second hepatitis B immunization at 9 AM. Approximately 20 minutes later, the employee returned to occupational health with complaints of dizziness, flushing of his face and clammy hands. BP 152/93; Pulse 88; Temp 98. The employee was evaluated and transported to the ED for further treatment. In ED, seen by doctor and examined. EKG, pulse Ox - 100%. Benadryl 50mg IV, Decadron 6mg IV. Patient feeling better and discharged. Follow up with PMD.
I had a sore throat, fever 101.2, chills, muscle aches, and nonproductive cough. I tested positive for COVID-19 at home. I went to the clinic, and they offered me Paxlovid. I was feeling better by then so I decided not to take the Paxlovid.
Fever, approximately 12 hours diarrhea, approximately 6-8 hours vomiting, nausea:  lasted approximately 12 hours chills, bodyache:  began approximately 6 hours after injection and continued until 24 hours after headache, 3-4 days
Information has been received from a physician concerning a male patient of unknown age. Information about concurrent condition, concomitant medication, drug allergies/reactions and medical history of the patient was unknown. On 27-JAN-2016, the patient received PROQUAD (strength, dose, route of administration, lot# and expiration date were not reported) diluted with sterile diluent (MERCK) for prophylaxis. From unspecified date in April 2016, the patient experienced waxing and waning hearing loss. The outcome of the event was reported as not recovered/not resolved. Causality assessment was not provided. Upon internal review, waxing and waning hearing loss was determined to be medically significant.
Low grade fever (99.2 degrees F); This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever (99.2 degrees F)) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PYREXIA (Low grade fever (99.2 degrees F)). At the time of the report, PYREXIA (Low grade fever (99.2 degrees F)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Mar-2021, Body temperature: 99.2 (Inconclusive) Low grade fever (99.2 degrees F).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was reported. No concomitant medication was reported.    Reporter did not allow further contact
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 30-JAN-2016 the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 07-FEB-2016, the patient was treated at a medical center for the onset of a vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering, and other damages. Additional information has been requested.
Information has been received from a medical assistant concerning her 18 year old daughter with Von Willebrand's disease and no known drug allergies who on 29-JAN-2007 was vaccinated with the first dose of GARDASIL (lot# 0011Y, valid for ROTATEQ 0.5ml, intramuscularly. On 26-MAR-2007 patient received the second dose of GARDASIL (lot# 0011Y, valid for ROTATEQ) 0.5ml intramuscularly, and on 05-AUG-2009 she received the third dose of GARDASIL (lot# 0073Y, valid for ROTATEQ) 0.5ml intramuscularly. Concomitant therapy included ORTHO-NOVUM. Patient did not receive any concomitant vaccinations when she received GARDASIL. In August 2008 (exact date not reported), the patient experienced hives intermittently in different locations ("she broke out in hives"). On 10-OCT-2008 the patient complained of joint pain in her arms. The joint pain went away and returned another time. The patient also complained of muscle spasm, severe joint pain and swelling, pain in her arms, shoulders, knees and legs with some outbreaks. During some of the outbreaks she is unable to walk without assistance. On 04-NOV-2008 the patient was seen by her physician, and had laboratory blood tests which revealed RA factor negative, SED rate 14, normal, CBC (results not reported). On 14-JAN-2009 the patient was seen one time by a rheumatologist. The patient was evaluated with no diagnosis. Rheumatologist was not able to determine the source of patient's symptoms. On 22-AUG-2009 the patient experienced bilateral hand to elbow pain and swelling. Patient had a scheduled appointment to see the physician (date not reported). At the time of this report the patient had not yet recovered but went back to school. This is one of two cases from the same source. Additional information has been requested.
Wide spread rash starting 9/7/13 numerous red papules with occasional central cloudy vesicles few erythematous macules on (B) palms & soles of feet lasting approx 1 week.